Picture of Evotec SE logo

EVT Evotec SE Income Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Annual income statement for Evotec SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue375446501618751
Cost of Revenue
Gross Profit112133126152174
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses298384452589725
Operating Profit77.562.648.629.126.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes7256.625.8237-154
Provision for Income Taxes
Net Income After Taxes84.137.26.28216-176
Minority Interest
Net Income Before Extraordinary Items
Net Income84.238.16.28216-176
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income84.238.16.28216-176
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.5220.3070.0551.36-1.02
Dividends per Share